4-[2-fluoro-5-[[(1R,2R,3S,4S)-3-[[4-fluoro-3-(pentafluoro-$l^6-sulfanyl)phenyl]carbamoyl]norbornan-2-yl]carbamoyl]-4-methoxy-phenoxy]-1-methyl-cyclohexanecarboxylic acid

ID: ALA5198814

Chembl Id: CHEMBL5198814

PubChem CID: 163395926

Max Phase: Preclinical

Molecular Formula: C30H33F7N2O6S

Molecular Weight: 682.66

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(F)c(O[C@H]2CC[C@@](C)(C(=O)O)CC2)cc1C(=O)N[C@@H]1[C@@H]2CC[C@@H](C2)[C@@H]1C(=O)Nc1ccc(F)c(S(F)(F)(F)(F)F)c1

Standard InChI:  InChI=1S/C30H33F7N2O6S/c1-30(29(42)43)9-7-18(8-10-30)45-23-13-19(22(44-2)14-21(23)32)27(40)39-26-16-4-3-15(11-16)25(26)28(41)38-17-5-6-20(31)24(12-17)46(33,34,35,36)37/h5-6,12-16,18,25-26H,3-4,7-11H2,1-2H3,(H,38,41)(H,39,40)(H,42,43)/t15-,16+,18-,25-,26+,30+/m0/s1

Standard InChI Key:  CDRWWKJURUZOFS-VMWYBRDSSA-N

Alternative Forms

  1. Parent:

    ALA5198814

    ---

Associated Targets(Human)

RXFP1 Tchem Relaxin receptor 1 (6345 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 682.66Molecular Weight (Monoisotopic): 682.1948AlogP: 7.83#Rotatable Bonds: 9
Polar Surface Area: 113.96Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.68CX Basic pKa: CX LogP: 6.61CX LogD: 3.21
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.23Np Likeness Score: -0.21

References

1. Sabnis RW..  (2022)  Novel RXFP1Modulators for Treating Heart Failure.,  13  (8.0): [PMID:35978692] [10.1021/acsmedchemlett.2c00321]

Source